MLchartDataset catalogue

VMP regimen

Term · Oncology and biomedicine · MLC-T-ONC-017521

A regimen consisting of melphalan, prednisone and bortezomib used for the treatment of plasma cell myeloma.

Table 1. Record
IdentifierMLC-T-ONC-017521
FieldOncology and biomedicine
AbbreviationMPB
Synonymsbortezomib/melphalan/prednisone; melphalan/prednisone/bortezomib; melphalan-prednisone-bortezomib regimen; melphalan/prednisone/Velcade; MPB regimen; Velcade/melphalan/prednisone
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017521",
  "term": "VMP regimen",
  "field": "Oncology and biomedicine",
  "definition": "A regimen consisting of melphalan, prednisone and bortezomib used for the treatment of plasma cell myeloma.",
  "abbreviation": "MPB",
  "synonyms": [
    "bortezomib/melphalan/prednisone",
    "melphalan/prednisone/bortezomib",
    "melphalan-prednisone-bortezomib regimen",
    "melphalan/prednisone/Velcade",
    "MPB regimen",
    "Velcade/melphalan/prednisone"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/vmp-regimen/"
}

Record 17,308 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.